Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors

References

• Villar-Garea A, Esteller M. Histone deacetylase inhibitors: understanding a new wave of anticancer agents. Int J Cancer 2004; 112:171 - 8; http://dx.doi.org/10.1002/ijc.20372; PMID: 15352027
   PubMed Web of Science ®Google Scholar
• Prince HM, Bishton MJ, Harrison SJ. Clinical studies of histone deacetylase inhibitors. Clin Cancer Res 2009; 15:3958 - 69; http://dx.doi.org/10.1158/1078-0432.CCR-08-2785; PMID: 19509172
   PubMed Web of Science ®Google Scholar
• Munster P, Marchion D, Bicaku E, Lacevic M, Kim J, Centeno B, et al. Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC. Clin Cancer Res 2009; 15:2488 - 96; http://dx.doi.org/10.1158/1078-0432.CCR-08-1930; PMID: 19318486
   PubMed Web of Science ®Google Scholar
• Candelaria M, Gallardo-Rincón D, Arce C, Cetina L, Aguilar-Ponce JL, Arrieta O, et al. A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Ann Oncol 2007; 18:1529 - 38; http://dx.doi.org/10.1093/annonc/mdm204; PMID: 17761710
   PubMed Web of Science ®Google Scholar
• Arce C, Pérez-Plasencia C, González-Fierro A, de la Cruz-Hernández E, Revilla-Vázquez A, Chávez-Blanco A, et al. A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer. PLoS One 2006; 1:e98; http://dx.doi.org/10.1371/journal.pone.0000098; PMID: 17183730
   PubMed Web of Science ®Google Scholar
• Mahalingam D, Medina EC, Esquivel JA 2nd, Espitia CM, Smith S, Oberheu K, et al. Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levels. Clin Cancer Res 2010; 16:141 - 53; http://dx.doi.org/10.1158/1078-0432.CCR-09-1385; PMID: 20028765
   PubMed Web of Science ®Google Scholar
• Chen X, Wong JY, Wong P, Radany EH. Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis. Mol Cancer Res 2011; 9:448 - 61; http://dx.doi.org/10.1158/1541-7786.MCR-10-0471; PMID: 21303901
   PubMed Web of Science ®Google Scholar
• Alimirah F, Chen J, Basrawala Z, Xin H, Choubey D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett 2006; 580:2294 - 300; http://dx.doi.org/10.1016/j.febslet.2006.03.041; PMID: 16580667
   PubMed Web of Science ®Google Scholar
• Seo SK, Jin HO, Woo SH, Kim YS, An S, Lee JH, et al. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. J Thorac Oncol 2011; 6:1313 - 9; http://dx.doi.org/10.1097/JTO.0b013e318220caff; PMID: 21642861
   PubMed Web of Science ®Google Scholar
• Schaeffer EM, Marchionni L, Huang Z, Simons B, Blackman A, Yu W, et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene 2008; 27:7180 - 91; http://dx.doi.org/10.1038/onc.2008.327; PMID: 18794802
   PubMed Web of Science ®Google Scholar
• Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 2009; 69:3364 - 73; http://dx.doi.org/10.1158/0008-5472.CAN-08-4210; PMID: 19351829
   PubMed Web of Science ®Google Scholar
• Kim SY, Volsky DJ. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 2005; 6:144; http://dx.doi.org/10.1186/1471-2105-6-144; PMID: 15941488
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M, et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A 2003; 100:605 - 10; http://dx.doi.org/10.1073/pnas.242716699; PMID: 12529507
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545 - 50; http://dx.doi.org/10.1073/pnas.0506580102; PMID: 16199517
   PubMed Web of Science ®Google Scholar
• Kortenhorst MS, Zahurak M, Shabbeer S, Kachhap S, Galloway N, Parmigiani G, et al. A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitors. Clin Cancer Res 2008; 14:6886 - 94; http://dx.doi.org/10.1158/1078-0432.CCR-08-0119; PMID: 18980983
   PubMed Web of Science ®Google Scholar
• Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, et al. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 2012; 40:3689 - 703; http://dx.doi.org/10.1093/nar/gkr1222; PMID: 22210864
   PubMed Web of Science ®Google Scholar
• Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007; 7:54 - 60; http://dx.doi.org/10.1038/nrc2044; PMID: 17186018
   PubMed Web of Science ®Google Scholar
• Ross AE, Marchionni L, Vuica-Ross M, Cheadle C, Fan J, Berman DM, et al. Gene expression pathways of high grade localized prostate cancer. Prostate 2011; http://dx.doi.org/10.1002/pros.21373; PMID: 21360566
   PubMed Web of Science ®Google Scholar
• Ross AE, Marchionni L, Phillips TM, Miller RM, Hurley PJ, Simons BW, et al. Molecular effects of genistein on male urethral development. J Urol 2011; 185:1894 - 8; http://dx.doi.org/10.1016/j.juro.2010.12.095; PMID: 21421236
   PubMed Web of Science ®Google Scholar
• He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J, et al. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells 2009; 27:1487 - 95; http://dx.doi.org/10.1002/stem.92; PMID: 19544456
   PubMed Web of Science ®Google Scholar
• Croft D, O’Kelly G, Wu G, Haw R, Gillespie M, Matthews L, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 2011; 39:Database issue D691 - 7; http://dx.doi.org/10.1093/nar/gkq1018; PMID: 21067998
   PubMed Web of Science ®Google Scholar
• Goel R, Harsha HC, Pandey A, Prasad TS. Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. Mol Biosyst 2012; 8:453 - 63; http://dx.doi.org/10.1039/c1mb05340j; PMID: 22159132
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al, The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat Genet 2000; 25:25 - 9; http://dx.doi.org/10.1038/75556; PMID: 10802651
   PubMed Web of Science ®Google Scholar
• Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, et al, Gene Ontology Consortium. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32:Database issue D258 - 61; http://dx.doi.org/10.1093/nar/gkh036; PMID: 14681407
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28:27 - 30; http://dx.doi.org/10.1093/nar/28.1.27; PMID: 10592173
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006; 34:Database issue D354 - 7; http://dx.doi.org/10.1093/nar/gkj102; PMID: 16381885
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008; 36:Database issue D480 - 4; http://dx.doi.org/10.1093/nar/gkm882; PMID: 18077471
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34:267 - 73; http://dx.doi.org/10.1038/ng1180; PMID: 12808457
   PubMed Web of Science ®Google Scholar
• Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2008; 36:Database issue D13 - 21; http://dx.doi.org/10.1093/nar/gkm1000; PMID: 18045790
   PubMed Web of Science ®Google Scholar
• Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res 2011; 39:Database issue D685 - 90; http://dx.doi.org/10.1093/nar/gkq1039; PMID: 21071392
   PubMed Web of Science ®Google Scholar
• Clauset A, Newman ME, Moore C. Finding community structure in very large networks. Phys Rev E Stat Nonlin Soft Matter Phys 2004; 70:066111; http://dx.doi.org/10.1103/PhysRevE.70.066111; PMID: 15697438
   PubMed Web of Science ®Google Scholar
• van den Elsen PJ, Holling TM, Kuipers HF, van der Stoep N. Transcriptional regulation of antigen presentation. Curr Opin Immunol 2004; 16:67 - 75; http://dx.doi.org/10.1016/j.coi.2003.11.015; PMID: 14734112
   PubMed Web of Science ®Google Scholar
• Gobin SJ, Peijnenburg A, Keijsers V, van den Elsen PJ. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 1997; 6:601 - 11; http://dx.doi.org/10.1016/S1074-7613(00)80348-9; PMID: 9175838
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Warren D, Spencer F, Kim IF, Biswal S, Frank BC, et al. Multiple-laboratory comparison of microarray platforms. Nat Methods 2005; 2:345 - 50; http://dx.doi.org/10.1038/nmeth756; PMID: 15846361
   PubMed Web of Science ®Google Scholar
• Bolanos-Garcia VM. Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies. Curr Cancer Drug Targets 2009; 9:131 - 41; http://dx.doi.org/10.2174/156800909787580980; PMID: 19275754
   PubMed Web of Science ®Google Scholar
• Philip PA, Benedetti J, Corless CL, Wong R, O’Reilly EM, Flynn PJ, et al. Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. J Clin Oncol 2010; 28:3605 - 10; http://dx.doi.org/10.1200/JCO.2009.25.7550; PMID: 20606093
   PubMed Web of Science ®Google Scholar
• Herbst RS, Ansari R, Bustin F, Flynn P, Hart L, Otterson GA, et al. Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial. Lancet 2011; 377:1846 - 54; http://dx.doi.org/10.1016/S0140-6736(11)60545-X; PMID: 21621716
   PubMed Web of Science ®Google Scholar
• Rosenthal SA, Bae K, Pienta KJ, Sobczak ML, Asbell SO, Rajan R, et al, Radiation Therapy Oncology Group Trial 9902. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02. Int J Radiat Oncol Biol Phys 2009; 73:672 - 8; http://dx.doi.org/10.1016/j.ijrobp.2008.05.020; PMID: 18990504
   PubMed Web of Science ®Google Scholar
• Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, et al. Functional discovery via a compendium of expression profiles. Cell 2000; 102:109 - 26; http://dx.doi.org/10.1016/S0092-8674(00)00015-5; PMID: 10929718
   PubMed Web of Science ®Google Scholar
• Tomasi TB, Magner WJ, Khan AN. Epigenetic regulation of immune escape genes in cancer. Cancer Immunol Immunother 2006; 55:1159 - 84; http://dx.doi.org/10.1007/s00262-006-0164-4; PMID: 16680460
   PubMed Web of Science ®Google Scholar
• Sharpe JC, Abel PD, Gilbertson JA, Brawn P, Foster CS. Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium. Br J Urol 1994; 74:609 - 16; http://dx.doi.org/10.1111/j.1464-410X.1994.tb09193.x; PMID: 7530126
   PubMedGoogle Scholar
• Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, et al. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res 2007; 67:5117 - 25; http://dx.doi.org/10.1158/0008-5472.CAN-06-4040; PMID: 17545589
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783 - 92; http://dx.doi.org/10.1056/NEJM200103153441101; PMID: 11248153
   PubMed Web of Science ®Google Scholar
• Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, et al. β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res 2011; 71:2600 - 10; http://dx.doi.org/10.1158/0008-5472.CAN-10-3382; PMID: 21427356
   PubMed Web of Science ®Google Scholar
• Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, et al. Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol 2006; 24:3089 - 94; http://dx.doi.org/10.1200/JCO.2005.04.5252; PMID: 16809734
   PubMed Web of Science ®Google Scholar
• van den Eertwegh AJ, Versluis J, van den Berg HP, Santegoets SJ, van Moorselaar RJ, van der Sluis TM, et al. Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol 2012; 13:509 - 17; http://dx.doi.org/10.1016/S1470-2045(12)70007-4; PMID: 22326922
   PubMed Web of Science ®Google Scholar
• Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al, IMPACT Study Investigators. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010; 363:411 - 22; http://dx.doi.org/10.1056/NEJMoa1001294; PMID: 20818862
   PubMed Web of Science ®Google Scholar
• Huber ML, Haynes L, Parker C, Iversen P. Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J Natl Cancer Inst 2012; 104:273 - 9; http://dx.doi.org/10.1093/jnci/djr514; PMID: 22232132
   PubMed Web of Science ®Google Scholar
• Khan AN, Tomasi TB. Histone deacetylase regulation of immune gene expression in tumor cells. Immunol Res 2008; 40:164 - 78; http://dx.doi.org/10.1007/s12026-007-0085-0; PMID: 18213528
   PubMed Web of Science ®Google Scholar
• Bernal M, Ruiz-Cabello F, Concha A, Paschen A, Garrido F. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes. Cancer Immunol Immunother 2012; 61:1359 - 71; http://dx.doi.org/10.1007/s00262-012-1321-6; PMID: 22833104
   PubMed Web of Science ®Google Scholar
• Ma X, Ezzeldin HH, Diasio RB. Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 2009; 69:1911 - 34; http://dx.doi.org/10.2165/11315680-000000000-00000; PMID: 19747008
   PubMed Web of Science ®Google Scholar
• Noh EJ, Lim DS, Jeong G, Lee JS. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. Biochem Biophys Res Commun 2009; 378:326 - 31; http://dx.doi.org/10.1016/j.bbrc.2008.11.057; PMID: 19038231
   PubMed Web of Science ®Google Scholar
• Kretzner L, Scuto A, Dino PM, Kowolik CM, Wu J, Ventura P, et al. Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. Cancer Res 2011; 71:3912 - 20; http://dx.doi.org/10.1158/0008-5472.CAN-10-2259; PMID: 21502403
   PubMed Web of Science ®Google Scholar
• Wissing MD, Mendonca J, Kortenhorst MSQ, Kaelber NS, Gonzalez M, Kim E, et al. Targeting prostate cancer through a combination of Polo-like kinase inhibitors and histone deacetylase inhibitors [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; 2010. Abstract nr 5414.
   Google Scholar
• Paller CJ, Wissing MD, Kim E, Kortenhorst MSQ, Gerber S, Rosen M, et al. Preclinical profile of AMG 900 in combination with HDACIs in prostate cancer [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; 2012. Abstract nr 2049.
   Google Scholar
• Chou YW, Chaturvedi NK, Ouyang S, Lin FF, Kaushik D, Wang J, et al. Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells. Cancer Lett 2011; 311:177 - 86; http://dx.doi.org/10.1016/j.canlet.2011.07.015; PMID: 21862211
   PubMed Web of Science ®Google Scholar
• van Diest PJ. No consent should be needed for using leftover body material for scientific purposes. For. BMJ 2002; 325:648 - 51; http://dx.doi.org/10.1136/bmj.325.7365.648; PMID: 12242180
   PubMed Web of Science ®Google Scholar
• Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comput Graph Statist 1996; 5:299 - 314
   Google Scholar
• Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5:R80; http://dx.doi.org/10.1186/gb-2004-5-10-r80; PMID: 15461798
   PubMed Web of Science ®Google Scholar
• Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:e3; http://dx.doi.org/10.2202/1544-6115.1027; PMID: 16646809
   PubMedGoogle Scholar
• Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005; 21:2067 - 75; http://dx.doi.org/10.1093/bioinformatics/bti270; PMID: 15657102
   PubMed Web of Science ®Google Scholar
• Smyth GK, Speed T. Normalization of cDNA microarray data. Methods 2003; 31:265 - 73; http://dx.doi.org/10.1016/S1046-2023(03)00155-5; PMID: 14597310
   PubMed Web of Science ®Google Scholar
• Smyth GK, Yang YH, Speed T. Statistical issues in cDNA microarray data analysis. Methods Mol Biol 2003; 224:111 - 36; PMID: 12710670
   PubMedGoogle Scholar
• Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey RV, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer; 2005. 397-420.
   Google Scholar
• Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, et al. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. [Published OnlineFirst January 5, 2012] Cancer Discov 2012; 2:236 - 47; http://dx.doi.org/10.1158/2159-8290.CD-11-0219; PMID: 22585994
   PubMed Web of Science ®Google Scholar
• Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2012; 40:Database issue D13 - 25; http://dx.doi.org/10.1093/nar/gkr1184; PMID: 22140104
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J R Stat Soc, B 1995; 57:289 - 300
   Google Scholar
• Roy S, Jeffrey R, Tenniswood M. Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells. Mol Cancer Ther 2008; 7:1931 - 9; http://dx.doi.org/10.1158/1535-7163.MCT-07-2353; PMID: 18645003
   PubMed Web of Science ®Google Scholar
• Vindeløv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3:323 - 7; http://dx.doi.org/10.1002/cyto.990030503; PMID: 6188586
   PubMedGoogle Scholar